EO 14398 HIV nuetralizing antiboby assay
Active Purchase Order Awarded Last action
- Contract number
- 75D30126P21115
- Awardee
-
Beth Israel Deaconess Medical Center, Inc. UEI C1CPANL3EWK4
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $8,118
Award facts
- Opportunity
-
- 75D30126Q78997 Solicitation number
- Contract value 100% obligated
- $8,118.00 Current and potential, with all options
- Completion date 44% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02215, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Centers for Disease Control and Prevention, Atlanta (CDC Pittsburgh) issued a purchase order to Beth Israel Deaconess Medical Center, Inc. for $8,118.00 on July 1, 2026, for an EO 14398 HIV neutralizing antibody assay with an ultimate completion date of April 30, 2027. Work is performed in Boston, Massachusetts. The order is firm fixed price with no set-aside designation applied.
Quick answers
Who was awarded contract 75D30126P21115?
75D30126P21115 was awarded to Beth Israel Deaconess Medical Center, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on July 1, 2026.
How much is contract 75D30126P21115 worth?
The government has obligated $8,118 on 75D30126P21115.
Was contract 75D30126P21115 competed?
The extent of competition for 75D30126P21115 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award